Table 2. Ex vivo expansion: Summary of product characteristics before and after expansion.

NO.	Before expansion				After expansion					Composition of Transplanted Grafts
	Volume of CB (ml)	MNC×107	% CD41+	Expansion time (day)	MNC×107	% CD41+	AbsoluteCD41+(×106)	Cell Viability	Fold expansion	Body Weight	MNC per kg b.w. (×106)	CD41+ cells per kg b.w. (×106)
1	78	4.5	6	11	58.5	52	304	91.4%	113	70	8.4	4.3
2	54	8	11	5	48	26	125	94.0%	14	61	7.9	2.0
3	69	24	4	7	264	33	871	98.7%	91	67	39.4	13.0
4	47	4.6	8	6	611	22	1344	98.0%	365	57	107.2	23.6
5	93	8.1	3	8	72.9	27	197	98.9%	81	92	7.9	2.1
6	82	16	8	7	128	22	282	99.0%	22	54	23.7	5.2
7	106	18	6	4	54	13	70	99.9%	6	60	9.0	1.2
8	52	4.6	9	17	87.4	64	559	97.1%	135	81	10.8	6.9
9	77	1.9	13	20	32.3	55	178	92.2%	7	67	4.8	2.7
10	62	6	6	4	36	9	32	99.0%	9	57	6.3	0.6
11	70	5	12	12	130	72	936	87.8%	156	79	16.5	11.8
12	77	7	5	14	119	67	797	93.0%	228	67	17.8	11.9
13	72	10	6	4	20	8	16	95.0%	3	63	3.2	0.3
14	78	9	9	12	198	77	1525	91.0%	188	70	28.3	21.8
15	86	10	8	14	310	54	1674	84.4%	209	86	36.0	19.5
16	99	15	6	7	120	23	276	93.7%	31	82	14.6	3.4
17	56	11	5	4	44	13	57	98.0%	10	78	5.6	0.7
18	93	9	5	8	135	37	500	84.0%	111	80	16.9	6.2
19	89	12	8	13	192	58	1114	95.1%	116	66	29.1	16.9
20	70	20	5	13	380	63	2934	92.0%	293	80	47.5	29.9
21	72	6	9	22	96	32	307	94.2%	57	50	19.2	6.1
22	102	29	6	6	132	18	238	93.9%	14	88	15.0	2.7
23	65	6.6	11	16	85	52	442	92.0%	61	78	10.9	5.7
24	75	5.1	8	11	56	48	269	90.2%	66	61	9.2	4.4
Median(range)	76(47–106)	8.55(1.9–29)	7(3–13)	9.5(4–22)	107.5(20–611)	35(8–77)	305.5(16–2934)	93.95%(84–99.90%)	73.5(3–365)	68.5(50–92)	14.8(3.2–107.2)	5.45(0.3–29.9)

CB, cord blood; MNC: mononuclear cells.